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David Varghese, MRCS,a,b Malay Deshpande, MSc,b Tao Xu, PhD,b Priya Kesari, MSc,b Sunil Ohri, MD, FRCS(CTh),a and
Thomas Boland, PhD,b Southampton, United Kingdom, and Clemson, SCTissue engineering may be defined as the science andengineering of functional tissues and organs for thereplacement of diseased body parts.1 Traditionally, thishas been done by the seeding of cellular material onto a
suitable scaffold material to create 3-dimensional constructs.2
However there are a number of drawbacks to this technique. The
degree of cellular penetration is variable and does not proceed
uniformly through the scaffold. Organs consist of varied cell types
in specific locations, and this is hard to replicate with this tech-
nique. Preformed, rigid scaffolds are not suitable for engineering
contractile tissues, such as myocardium or vascular conduits. Per-
haps the single most limiting factor with solid scaffold design is
that of providing the developing structure with a vascular supply.
Many of the top-down fabrication techniques that have been de-
veloped relate to the manufacture of microelectromechanical de-
vices and are therefore unsuitable for biologic systems. It is there-
fore necessary to develop other strategies for assembling tissuelike
constructs, a strategy that allows the creation of structures with
distinct shapes and functions that are nurtured by vascular con-
nectivity incorporating methods of vascularizing large, living,
3-dimensional tissue-engineered constructs.
Adapting bottom-up approaches to tissue engineering is a gen-
uine challenge. Since the first application of fused deposition
modeling for tissue engineering scaffolds,3 considerable effort has
been focused on printing synthetic biodegradable scaffolds.4 Con-
currently, a variety of rapid prototyping techniques have been
developed to define macroscopically the shapes of deposited bio-
materials, including photolithography,5 syringe-based gel deposi-
tion,6 and solid freeform fabrication.7,8 That these approaches have
not yet led to the construction of harmonically organized complex
tissues may be due to the difficulty of embedding the various cell
types within the intricate designs. Our tissue engineering approach
combines rapid prototyping procedures with microencapsulation to
print viable freeform structures with custom-modified ink-jet print-
ers.9-11 Inspired by developmental biology, this approach may
provide the necessary cues, rules, and framework for hierarchic
self-assembly. With this innovative technique, it is possible to
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create tissues faster than is possible with current methods.
In brief, ink-jet printers are modified by disabling the paper-
feed mechanism and incorporating a stepper motor–controlled
z-axis platform. An alginate-coated frame is used as a scaffold and
was mounted on this z-axis platform. The ink cartridge is filled
with bovine aortic endothelial cells in culture medium (bioink).
This bioink is printed layer by layer, deep to superficial, onto the
scaffold, resulting in a tubular structure measuring 50 mm long
with an outer diameter of 4 mm.
We have printed tubes of many cell types this way, including
Chinese hamster ovary cells, endothelial cells (Figure 1),
smooth muscle cells, osteoblasts, and stem cells. Our initial
studies focused on cellular viability, reducing bacterial contam-
ination, and optimizing conditions of in vitro culture. We have
printed dense, fused structures that can exhibit function when
challenged with agonists in simple in vitro experiments. These
include vasoconstriction properties of printed smooth muscle
cell tubes and the potential of printed stem cells to differentiate
into multiple lines, although we do not know yet how to control
this differentiation.
Vital to the cell patterning procedures is the use of stable,
aqueous, noncytotoxic bioinks that act as cross-linking agents
delivered by the ink-jet method into a rapid prototyping chamber.
There is a need to develop biomaterials that can be used as bioinks;
current strategies for bioinks include natural and synthetic physical
hydrogels,11 concentrated cell pellets,10 and collagen solutions. An
alternative solution would be the seeding of different cell types
directly onto a pliable scaffold, stacking the layers together and
rolling them into tubular structures. Clearly, this technology is still
in its infancy. Considerable improvements in the biomaterials used
as bioinks and scaffolds will be needed before any clinical appli-
cations can be realized. Optimizing the rheologic and surface
properties of the inks and designing printers optimized for these
properties will improve cell density of the printed constructs and
the speed at which tissues may be manufactured. Incorporation of
controlled-release particles loaded with growth factors or signaling
molecules into bioinks opens interesting avenues for combining
cell printing with other potential therapeutic modalities.
A model of how this technique may be used for the assembly
of more complex tissues is schematically shown in Figure 2. The
first step is the detailed creation of a computer model of the
structure to be created. The bioengineer will need to build up a
layer-by-layer picture of the organ to be created by specifying the
location, number, and type of cell within each layer. Once a
computer-aided design file has been constructed, it can be saved
and reused any number of times. The computer-aided design file is
then transferred to the organ printer. This will be a purpose-built
unit consisting of multiple nozzles and cartridges containing the
different cell types and growth factors. The organ printer will have
to be enclosed in a sterile environment in which the required
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Brief Communicationsstructure is built layer by layer. Cellular viability will be main-
tained by choosing biocompatible polymers dissolved in isotonic
buffer solution or culture media and noncytotoxic cross-linkers.
Figure 2. Diagrammatic roadmap for organ printing.
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Brief Communicationsmethod has the potential to revolutionize the field of cardiotho-
racic surgery. Most of all, the continued joint efforts of devel-
opmental biologists and material scientists and engineers in the
area of cell printing may lead to faster tissue construction, a
cornerstone to making regenerative medicine a clinical possi-
bility.
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Selective reduction of the septolateral dimensions in functional mitral
regurgitation by modified-shape ring annuloplasty
Francesco Maisano, MD,a Zvi Ziskind, MD,a Antonio Grimaldi, MD,b Andrea Blasio, MD,a Alessandro Caldarola, MD,aAlfieri, MD,a Milan, ItalyUndersized annuloplasty is the conventional surgicaltreatment for functional mitral regurgitation (FMR).1The rationale of this approach is the reduction theannular diameter to force leaflet coaptation. When this
technique is performed with a conventional annuloplasty prosthe-
sis, the transverse and septolateral dimensions are proportionally
reduced. However, it has been suggested that the main determinant
of malcoaptation in FMR is the increase of the septolateral dimen-
sion.2 Therefore, intercommissural distance reduction is probably
unnecessary, if not detrimental (it may induce anterior leaflet
folding and unnecessary reduction of the total mitral valve orifice
area).
We herein present an alternative method for annuloplasty,
designed to selectively reduce the septolateral dimension in FMR,
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Surgical Technique and Clinical Experience
A Carpentier rigid ring (Edwards Lifesciences Inc, Irvine, Calif)
was chosen because it contains a metal core that can be reshaped.
Prosthesis size was selected by measuring the intertrigonal dis-
tance and was undersized by 1 size. Before implantation, the ring
was reshaped according to the sequence illustrated in Figure 1 by
use of 2 tubing clamps. Shape modification created a prosthesis
with the intertrigonal distance upsized by 1 size (and therefore
normalized to the native valve intertrigonal dimension) and the
septolateral distance undersized by 1 size (therefore, the septolat-
eral dimension was doubly undersized), resulting in a nearly 2:1
intercommissural-septolateral ratio (as compared with the standard
4:3 ratio).
We used this approach in 14 patients with FMR between March
and December 2003. There were 12 men and 2 women, with a
mean age of 56  11 years. Ten patients had ischemic and 4 had
idiopathic cardiomyopathy. Preoperative mean functional class
was 2.6  0.6. FMR was severe in 12 patients and moderate in 2
(the mean regurgitation grade was 3.8 0.6). The mean coaptation
depth was 1.09  0.44 cm (range, 0.6-2.0 cm) and exceeded 1 cm
in 6 patients.4 A complex regurgitant jet (eccentric or multiple)
was detected in 9 patients.5 The mean tenting area was 2.1  0.82
cm2 (range, 1.3-4 cm2). The mean size of the implanted Carpentier
ring was 29.7  2.6. Associated procedures included the edge-to-
edge procedure (12 patients), coronary revascularization (10 pa-
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